Sean Parker sets up $250m cancer immunotherapy collaboration

A $250m (£177m) grant from Silicon Valley billionaire Sean Parker, announced on 13 April, aims to speed development of more effective cancer treatments by fostering collaboration among leading researchers in the field. The Parker Institute for Cancer Immunotherapy will include over 40 laboratories and more than 300 researchers from six key cancer centres. Apr 14, 2016